Cognitive adverse effects of chemotherapy in breast cancer patients
- PMID: 18660726
- DOI: 10.1097/SPC.0b013e32813a328f
Cognitive adverse effects of chemotherapy in breast cancer patients
Abstract
Purpose of review: This article reviews the most recent literature on chemotherapy-associated cognitive changes in women with breast cancer.
Recent findings: Most cross-sectional studies reported neuropsychological impairment in patients treated with chemotherapy, but the prevalence was variable. Prospective studies documented cognitive dysfunction in subgroups of patients treated with chemotherapy, but other reports found no evidence of impairment. Studies using neuroimaging techniques and animal models have begun to examine structural and functional correlates of cognitive changes associated with chemotherapy.
Summary: Significant advances have been made in the study of chemotherapy-related cognitive dysfunction over the past 10 years. The investigation of additional factors that may contribute to cognitive outcome, such as the effects of treatments other than chemotherapy and genetic susceptibility, is likely to further advance the field.
Similar articles
-
Neurocognitive changes in cancer survivors.Cancer J. 2008 Nov-Dec;14(6):396-400. doi: 10.1097/PPO.0b013e31818d8769. Cancer J. 2008. PMID: 19060604 Review.
-
The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.Brain Cogn. 2005 Oct;59(1):60-70. doi: 10.1016/j.bandc.2005.05.001. Epub 2005 Jun 21. Brain Cogn. 2005. PMID: 15975700 Review.
-
The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.Cancer. 2004 Jun 1;100(11):2292-9. doi: 10.1002/cncr.20272. Cancer. 2004. PMID: 15160331 Clinical Trial.
-
Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.Psychooncology. 2008 Dec;17(12):1189-95. doi: 10.1002/pon.1342. Psychooncology. 2008. PMID: 18506671
-
The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients.Psychooncology. 2009 Jun;18(6):674-8. doi: 10.1002/pon.1454. Psychooncology. 2009. PMID: 19021129 Clinical Trial.
Cited by
-
Cognitive effects of hormone therapy in men with prostate cancer: a review.Cancer. 2008 Sep 1;113(5):1097-106. doi: 10.1002/cncr.23658. Cancer. 2008. PMID: 18666210 Free PMC article. Review.
-
Scale-free brain dynamics under physical and psychological distress: pre-treatment effects in women diagnosed with breast cancer.Hum Brain Mapp. 2015 Mar;36(3):1077-92. doi: 10.1002/hbm.22687. Epub 2014 Nov 11. Hum Brain Mapp. 2015. PMID: 25388082 Free PMC article.
-
Dysregulation in myelination mediated by persistent neuroinflammation: possible mechanisms in chemotherapy-related cognitive impairment.Brain Behav Immun. 2014 Jan;35:23-32. doi: 10.1016/j.bbi.2013.07.175. Epub 2013 Aug 2. Brain Behav Immun. 2014. PMID: 23916895 Free PMC article.
-
Astaxanthin Ameliorates Doxorubicin-Induced Cognitive Impairment (Chemobrain) in Experimental Rat Model: Impact on Oxidative, Inflammatory, and Apoptotic Machineries.Mol Neurobiol. 2018 Jul;55(7):5727-5740. doi: 10.1007/s12035-017-0797-7. Epub 2017 Oct 16. Mol Neurobiol. 2018. PMID: 29039023
-
Pre-chemotherapy differences in visuospatial working memory in breast cancer patients compared to controls: an FMRI study.Front Hum Neurosci. 2011 Nov 1;5:122. doi: 10.3389/fnhum.2011.00122. eCollection 2011. Front Hum Neurosci. 2011. PMID: 22053153 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous